Rate of metabolic syndrome doesn’t change among HIV-infected people
New HIV therapies have contributed to a decrease in AIDS deaths, but physicians suspected the more potent medications led to symptoms characteristic of metabolic syndrome. However, now researchers at the School of Medicine have found that the rate of metabolic syndrome in HIV-infected patients is virtually identical to that in uninfected people.
Metabolic syndrome as common in HIV-infected people as in general population
New HIV therapies have contributed to a decrease in AIDS deaths, but physicians suspected the more potent medications led to symptoms characteristic of metabolic syndrome. However, now researchers at Washington University School of Medicine in St. Louis have found that the rate of metabolic syndrome in HIV-infected patients is virtually identical to that in uninfected people. Furthermore, the type or duration of HIV therapy did not affect the rate of metabolic syndrome.